China Universal Asset Management Company’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.41M Sell
9,986
-938
-9% -$205K 0.14% 110
2026
Q1
$2.07M Buy
10,924
+1,022
+10% +$179K 0.16% 109
2025
Q4
$1.68M Sell
9,902
-731
-7% -$112K 0.13% 125
2025
Q3
$1.4M Sell
10,633
-1,750
-14% -$210K 0.12% 140
2025
Q2
$1.31M Buy
12,383
+201
+2% +$21.8K 0.12% 140
2025
Q1
$1.51M Sell
12,182
-637
-5% -$83.1K 0.14% 137
2024
Q4
$1.58M Buy
12,819
+942
+8% +$111K 0.15% 119
2024
Q3
$1.32M Buy
11,877
+4,472
+60% +$490K 0.15% 120
2024
Q2
$790K Sell
7,405
-4,593
-38% -$505K 0.11% 121
2024
Q1
$1.44M Buy
11,998
+4,718
+65% +$578K 0.18% 100
2023
Q4
$895K Buy
7,280
+5,654
+348% +$706K 0.17% 113
2023
Q3
$210K Buy
1,626
+787
+94% +$105K 0.06% 146
2023
Q2
$104K Sell
839
-14
-2% -$1.88K 0.03% 152
2023
Q1
$125K Buy
853
+214
+33% +$31.7K 0.04% 127
2022
Q4
$102K Buy
639
+52
+9% +$7.62K 0.04% 122
2022
Q3
$78K Buy
+587
New +$89.3K 0.03% 115

Other funds holding JAZZ

China Universal Asset Management Company's JAZZ Position: Q2 2026 in Review

China Universal Asset Management Company reduced its Jazz Pharmaceuticals (JAZZ) stake by 8.6% in Q2 2026, selling an estimated $205K and leaving 9,986 shares worth $2.41M. The position accounts for 0.14% of the portfolio, ranked #110.

China Universal Asset Management Company first reported a position in JAZZ in Q3 2022 and has held it in 16 quarters since. 218 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • China Universal Asset Management Company held 9,986 shares of Jazz Pharmaceuticals worth $2.41M as of Q2 2026.
  • China Universal Asset Management Company sold 938 Jazz Pharmaceuticals shares in Q2 2026, an estimated $205K.
  • Jazz Pharmaceuticals made up 0.14% of China Universal Asset Management Company's portfolio in Q2 2026, its #110 holding.
  • China Universal Asset Management Company first reported a position in Jazz Pharmaceuticals in Q3 2022 and has held it in 16 quarters since.
  • 218 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.